Ocean Clinic, Marbella, Spain.
Department of Hand, Plastic, and Aesthetic Surgery, Ludwig Maximilian University, Munich, Germany.
J Cosmet Dermatol. 2021 Nov;20(11):3482-3491. doi: 10.1111/jocd.14502. Epub 2021 Oct 1.
BACKGROUND: Current options for the reduction of acne scarring (eg, ablative laser resurfacing) are associated with considerable side effects and limitations in terms of patient population. Percutaneous collagen induction via microneedling poses an alternative treatment method due to its low rates of reported adverse events and side effects. OBJECTIVE: To assess the safety and effectiveness of microneedling treatments in reducing acne scars. METHODS: A total of 22 patients (18 females and 4 males) with a mean age of 38 ± 7.6 years were assessed regarding the appearance of facial acne scarring. Acne scars were assessed via the Acne Scar Assessment Scale (ASAS) and the Goodman and Baron acne scar grading scale before and after two/three treatments. Additionally, the post-interventional development of side reactions, adverse events, and patient-reported outcomes (eg, pain/discomfort, skin redness) was reported. RESULTS: Compared to baseline, the mean ASAS value was improved statistically significantly on average by 1.41 and 1.46 after the second treatment as assessed by the independent raters and the patients, respectively. In patients who received a total of three treatments, a statistically significant mean improvement in ASAS value of 1.35 and 1.66 compared to baseline was assessed by the independent raters and patients, respectively. No unexpected adverse events were reported. The severity and rate of side reactions decreased over the course of this study. CONCLUSION: Microneedling treatments can pose a safe and effective option in the reduction of acne scarring. In this study, microneedling helped achieving a significant reduction of acne scars while showing high patient safety.
背景:目前用于减少痤疮疤痕(例如,磨皮激光换肤)的方法存在相当大的副作用和患者人群方面的局限性。微针穿刺诱导的经皮胶原诱导因其不良反应和副作用发生率低,成为一种替代治疗方法。 目的:评估微针治疗减少痤疮疤痕的安全性和有效性。 方法:共评估了 22 名(18 名女性和 4 名男性)年龄平均为 38 ± 7.6 岁的患者面部痤疮疤痕的外观。痤疮疤痕采用痤疮疤痕评估量表(ASAS)和 Goodman 和 Baron 痤疮疤痕分级量表进行评估,在两次/三次治疗前后进行评估。此外,还报告了干预后不良反应、不良事件和患者报告的结果(例如,疼痛/不适、皮肤发红)的发展情况。 结果:与基线相比,独立评估者和患者分别评估的第二次治疗后平均 ASAS 值分别平均改善了 1.41 和 1.46。接受总共三次治疗的患者中,独立评估者和患者分别评估的 ASAS 值平均改善了 1.35 和 1.66,与基线相比有统计学显著差异。未报告意外不良事件。不良反应的严重程度和发生率在研究过程中降低。 结论:微针治疗可作为减少痤疮疤痕的安全有效选择。在这项研究中,微针治疗有助于显著减少痤疮疤痕,同时显示出较高的患者安全性。
J Cosmet Dermatol. 2021-11
J Cosmet Dermatol. 2018-6
J Cosmet Dermatol. 2014-9
Front Med (Lausanne). 2024-7-10